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Background/aim: The aim of this paper is to provide the long-term surgical outcome of patients with intracranial intraventricular
tumors.
Materials and methods: Twenty-five patients operated on for intraventricular tumors between June 1999 and June 2014 are reviewed.
Data from before, during, and after surgery were obtained from the patients’ files and patients were followed regularly after surgery.
Results: The group of patients comprised 15 females and 10 males with a mean age of 31.6 ± 16 years. The majority were adults and only
3 children were included. Three, 4, and 18 patients had tumors in the 4th, 3rd, and frontal horn of the lateral ventricles, respectively.
All patients showed a varying degree of hydrocephalus and headache was the most common presenting symptom. Overall, central
neurocytoma was the most common pathological diagnosis. Complications were found in only 4 patients and, in long-term follow-up,
3 patients had died due to the malignant nature or upgrading to a malignant tumor and the rest were alive.
Conclusion: Total removal of the intraventricular tumor increases survival because the majority of these tumors are benign and slowgrowing. The type of surgical intervention should be chosen according to the location of the tumor in the ventricular system.
Key words: Intraventricular tumors, long-term, transcallosal, transcortical, follow-up, ventricle

1. Introduction
Intraventricular tumors of the brain are rare clinical
entities that account for 10% of all intracranial tumors (1)
and the lateral ventricle is the commonest location to be
involved within the ventricular system (2). They generally
are benign and slow-growing, such that patients may not
show any signs or symptoms until tumors reach large sizes.
Since they generally cause obstruction of cerebrospinal
fluid (CSF) circulation, signs and/or symptoms of
increased intracranial pressure due to hydrocephalus are
the most common presentations.
It is clear from the current literature that the best
treatment option for these tumors is surgical removal,
which should aim for total removal as much as possible
(3,4). The type of surgical approach generally depends
on the location of the tumor in the ventricular system
and planning the approach should allow minimal normal
parenchyma retraction and maximal tumor resection. Type
of surgical approach, such as using natural ways such as sulci
or interhemispheric sulcus or transcortical way especially
in tumors located in the lateral ventricle, is a still matter of
discussion. However, the common idea is that any surgical
approach causing less damage to the surrounding neural
* Correspondence: tanerato2000@yahoo.com
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structures and providing maximum resection should be
chosen. In addition to the microsurgical removal, recent
years show us that endoscopic resection of these tumors
is also possible, which is minimally invasive surgery (5).
We have to underline that every surgical approach to
these deep-seated tumors has its own advantages and
disadvantages.
In this paper, we aimed to provide long-term surgical
outcomes (i.e. follow-up of at least 1 year) of 25 patients
with intraventricular tumors, and our intention is not to
claim that one approach is superior to another. Data in
the current literature with respect to long-term surgical
outcome of intraventricular tumors are scarce and a
realistic assessment of these tumors will only become
possible as we get more experience based on reports from
all over the world.
2. Materials and methods
2.1. Patients
This retrospective analysis included 25 consecutive
patients who were operated on for intraventricular tumors
between June 1999 and June 2014 in the Department of
Neurosurgery, Cerrahpaşa Medical Faculty of İstanbul
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University. Data from before, during, and after surgery
were retrieved from the patients’ charts. All patients were
operated on by the same surgery and anesthesiology teams
and were followed regularly. Before and early after (within
72 h) surgery, magnetic resonance imaging (MRI) with and
without contrast agent was done for all patients and they
were seen in our outpatient clinic every year. At the last
follow-up, all patients were checked by MRI for evaluation
of recurrence or progression of any residue. Clinical
and seizure outcomes and medication use, especially
antiepileptic drug (AED) use, were also evaluated. Since
this is a retrospective analysis, approval from the local
ethics committee was not requested. All patients were
discussed with respect to type of surgical intervention at
our routine “preoperative meeting” in the department.
2.2. Statistical analysis
We used a commercially available statistical software
package (SPSS 14.0, SPSS Inc., Chicago, IL, USA) for
all the statistical analyses. Results were summarized by
using mean ± standard deviation for each parameter.
The chi-square test for categorical variables was used as
appropriate. Differences were considered statistically
significant if P < 0.05.
3. Results
3.1. Patients’ demographics
The 25 patients included 15 females (60%) and 10 males
(40%) with a mean age of 31.6 ± 16 years, ranging from
6 to 60 years. No statistically significant difference was
found regarding sex in this series (P = 0.31; χ2 test). The
majority of patients except three were adults and ages of
the three children were as follows: 6, 7, and 8 years. Table 1
summarizes the patients’ demographics.
3.2. Clinical characteristics
The presenting symptom was headache, found in 14
patients (56%), followed by nausea/vomiting (12%)
and vertigo (12%). In 2 patients, tumors were found
incidentally while seeking medical attention for some other
reason. One patient complained of decrease in vision and
the other had weakness on one side. Interestingly, seizure
was the sole symptom in only one patient. Neurologic
examination depending on the Royal Medical Research
Council Grading Scale (6) disclosed nothing abnormal in
14 patients (56%) and 3 patients had weakness on one side.
Two patients showed cerebellar signs included dysmetria
and dysdiadochokinesia and had a tumor in the 4th
ventricle. Nystagmus was found in 2 patients with fontal
horn tumor (Table 1).
3.3. Tumor characteristics
Since imaging characteristics have been reported in detail
in the current literature, radiological features will not be
discussed here. Three in the 3rd, four in the 4th, and 18

(72%) tumors in the frontal horn of the lateral ventricle
were identified by head MRI. There were no side preferences
regarding frontal horn location and all except one in the
lateral ventricle occupied frontal horn and the body. One
patient had a tumor involving the frontal horn and body
that had extended to the atrium. Almost all had caused
hydrocephalus but none required a ventriculoperitoneal
shunt (VP-shunt) before tumor removal. None of them
required cerebral angiography before surgery.
3.4. Surgery
Every patient was discussed in detail at a preoperative
meeting and the type of surgical intervention was chosen
depending on tumor location in the ventricular system and
imaging characteristics. Three patients with 4th ventricular
tumors were best treated by suboccipital craniectomy and
a telovelar approach. In 4 patients with 3rd ventricular
tumors, interhemispheric-transcallosal intervention
was performed in 3 and in one patient a transcorticaltransforaminal (foramen of Monro) route was chosen. In
18 patients with lateral ventricular tumors, 6 (33.3%) were
removed by interhemispheric-transcallosal intervention,
and in 10 (55.5%) transcortical intervention was preferred.
Two patients had combined surgical procedures because
of the extension of the tumor to the atrium. The main
reason for the interhemispheric-transcallosal approach in
this series was closeness of tumor to the midline, and if it
extended to the lateral part and compressed the caudate
nucleus and thalamus, the transcortical approach was
the first choice in order to not cause any harm to these
vital neuronal structures. In addition, for tumor size of
more than 3 cm in diameter, a transcortical approach
is better tolerated by patients and removal of the parts
close to the lateral roof is possible. It is difficult to see the
part of the tumor close to the lateral roof of the ventricle
under a microscope by interhemispheric-transcallosal
approach. One of the two patient merits discussing here
why we performed combined procedures. That patient
(no. 16 in the tables) (Figures 1a–1g) was treated by
interhemispheric-transcallosal approach and the tumor
had to be removed subtotally because of difficulty to
see and manipulate the lateral part of the tumor under
the lateral roof of the ventricle. Therefore, a second
intervention, which was transcortical, was performed, and
total removal was achieved.
The total number of surgeries was 33 and eight
patients were operated on twice or three times because
of recurrence or removal of residue (Table 2). In the first
surgery, 16 (64%) and 9 (36%) total and subtotal removals,
respectively, were performed (Table 2). The major reasons
for subtotal removal were the facts that some tumors
showed massive bleeding, some showed invasion of the
vital structures, and, in some, total removal was thought
to be performed after surgery but on early imaging residue
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Table 1. Summary of clinical data of the 25 patients included here.
No.

Age

Sex

Symptoms

Findings

Side

Site

First pathology

1*

25

F

Headache

None

Right

Frontal horn

SEGA (I)

2

40

F

N/V

Ataxia

Left

Frontal horn

Ependymoma (II)

3

55

F

None

Paresis

Midline

3rd ventricle

Craniopharyngioma (I)

4

55

M

Headache

Cerebellar findings

Midline

4th ventricle

Papilloma (II)

5*

7

F

Headache

None

Midline

4th ventricle

Ependymoma (II)

6

37

M

Headache

None

Left.

Frontal horn

Neurocytoma (II)

7

60

F

Headache

Cerebellar findings

Left

Frontal horn

GBM (IV)

8

50

F

Headache

None

Right

Frontal horn

Epidermoid cyst (I)

9

31

F

Headache

None

Midline

3rd ventricle

Colloid cyst

10

27

F

Headache

None

Right

Frontal horn

Colloid cyst

11

50

F

Headache

None

Left

Frontal horn

Subependymoma (II)

12

29

F

Headache

Nystagmus

Left

Frontal horn

Neurocytoma (II)

13

36

F

Vertigo

Paresis

Midline

4th ventricle

Ganglioglioma (I)

14*

13

M

Headache

None

Left

Frontal horn

Astrocytoma (II)

15

8

M

Headache

None

Midline

3rd ventricle

Craniopharyngioma (I)

16*

26

F

Headache

Nystagmus

Left

Frontal horn

Neurocytoma (II)

17

28

M

Headache

None

Right

Frontal horn

Neurocytoma (II)

18

30

M

Vertigo

None

Right

Frontal horn

Neurocytoma (II)

19

23

M

Weakness

Paresis

Right

Frontal horn

Neurocytoma (III)

20

6

M

Seizure

None

Left

Frontal horn

Ependymoma (III)

21*

39

M

Vertigo

None

Right

Frontal horn

Ganglioneurocytoma**

22

33

M

None

None

Right

Frontal horn

Low-grade glioma (II)

23

22

F

D/V

Paresis

Right

Frontal horn

Neurocytoma (II)

24*

21

F

N/V

None

Midline

3rd ventricle

Low-grade glioma (II)

25

40

F

Headache

None

Left

Frontal horn

Ependymoma (II)

D/V: Decrease in vision; GBM: glioblastoma multiforme; SEGA: subependymal giant cell astrocytoma; N/V: nausea and vomiting.
*Patients had more than one surgery. **Malign ganglioneurocytoma. Cerebellar findings include dysmetria and dysdiadochokinesia.

was seen. In two of the six patients who underwent second
surgeries, subtotal resection had to be done, and 2 patients
underwent third surgeries in which total removal was
achieved.
3.5. Pathological findings
Histopathological diagnosis after the first surgery revealed
that the most common finding was central neurocytoma,
which was seen in 7 patients (28%), followed by ependymoma
in 4 patients (16%) (Table 1). After the first surgery, the
majority of tumors were diagnosed as low-grade (grades
I and II), seen in 21 patients (84%), and in 4 patients they
were high-grade, such as glioblastoma multiforme (GBM;
grade IV), neurocytoma (grade III), ependymoma (grade
III), and malignant ganglioneurocytoma. Histopathologic
diagnosis after the second surgery was unchanged in
4 patients, but one patient was upgraded to anaplastic
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astrocytoma (grade III) within 6 months (patient no.
14 in the tables) and another one was upgraded to GBM
(grade IV) within 12 months (patient no. 24 in tables).
Two patients underwent a third surgery and the diagnoses
were malignant ependymoma (grade III) upgraded from
grade II ependymoma (patient no. 5 in tables) and GBM
(grade IV) upgraded from anaplastic astrocytoma (grade
III) (patient no. 14 in tables). During the follow-up period,
upgrading was encountered in three patients (12%). In
the 3rd ventricle, 2 had craniopharyngioma, one had a
colloid cyst, and in one GBM was diagnosed. After the
first surgery choroid plexus papilloma, ependymoma,
and ganglioglioma were the three diagnoses in the 4th
ventricle. In 18 patients with lateral ventricle tumors, the
most common pathology was central neurocytoma seen in
7 patients (38.8%), followed by 3 (16.6%) ependymomas.
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Figure 1. This 26-year-old female (patient no. 16 in the tables) was admitted to our clinic complaining of headache. Contrasted axial (a)
and sagittal (b) planes of the head MRI showed heterogeneous mass lesion within the left frontal horn of the lateral ventricle causing
massive dilatation of the ventricles. The tumor was mainly located in the atrium and the body. The patient underwent surgery, in which
an interhemispheric-transcallosal approach was chosen. After becoming certain that the entire tumor was removed, the surgery was
terminated. However, early head axial (c) and sagittal (d) MRI showed a residue on the most lateral part of the ventricle. A second
surgery was planned and this time a transcortical approach to the left middle frontal gyrus was performed. The rest of the tumor was
removed in toto and head MRI after the second surgery showed no tumor (e and f). The patient was diagnosed with neurocytoma (grade
II) and discharged from the hospital without any clinical sequelae. At the last follow-up (28 months after surgery), contrasted head MRI
(g and h) showed no residue or recurrence and the patient was doing well without any medications.

3.6. Early postoperative care and complications
After completion of tumor resection, an external
ventricular drain (EVD) was inserted into the ventricular
system to drain CSF and blood. As our routine surgical

procedure the EVD was kept for 3 days and then was
closed to see whether patients tolerated it. If no clinical
signs/symptoms existed, it was removed. All patients were
transferred to our intensive care unit and stayed overnight
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Figure 1. (Continued).

and AEDs were given to all, except for patients who were
operated on for 4th ventricular tumors. Any patient who
was diagnosed with high-grade tumors (grade III and IV)
was advised to receive radiation and chemotherapy for
further treatment.
A total of 4 patients (16%) showed complications early
after surgery: three patients after the first surgery and one
after the third surgery. One had hydrocephalus after the
EVD was removed and underwent a VP-shunt. At the last
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follow-up, the patient was free of any clinical problems.
One had a CSF fistula after removal of a tumor within the
4th ventricle and underwent repair. At the last follow-up,
the patient was doing well. One patient who was 7 years old
showed dysphasia and respiratory problems after the third
surgery. The patient underwent a tracheotomy and at the
last follow-up (2 months after the third surgery) the patent
still had the tracheotomy without neurological deficit.
Another patient who was operated on for a 3rd ventricular
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Table 2. Surgical outcome at the last follow-up of the 25 patients.
No.

1st Sx

2nd Sx

3rd Sx

Clinical findings

Head MRI

Survival time (months)

1

STR

STR

-

None

No tumor

51/alive

2

GTR

-

-

Ataxia

No tumor

49/alive

3

GTR

-

-

None

No tumor

50/alive

4

GTR

-

-

Cerebellar findings

No tumor

51/alive

5

STR

STR

GTR

None

No tumor

48/alive

6

GTR

-

-

None

No tumor

24/alive

7

GTR

-

-

Hemiparesis (4/5)

Recurrence

13/died

8

GTR

-

-

None

No tumor

33/alive

9

GTR

-

-

None

No tumor

29/alive

10

GTR

-

-

None

No tumor

29/alive

11

GTR

-

-

None

No tumor

12/alive

12

GTR

-

-

None

No tumor

47/alive

13

STR

-

-

Dysarthria, dysphagia

Residue

43/alive

14

STR

GTR

GTR

Decreased consciousness

Recurrence

12/died

15

STR

-

-

Visual field defect

Residue

17/alive

16

STR

GTR

-

None

No tumor

28/alive

17

GTR

-

-

Hemiparesis (4/5)

No tumor

20/alive

18

GTR

-

-

None

No tumor

23/alive

19

GTR

-

-

None

No tumor

47/alive

20

GTR

-

-

None

No tumor

52/alive

21

STR

GTR

-

None

Residue

61/alive

22

GTR

-

-

None

No tumor

50/alive

23

STR

-

-

None

Residue

53/alive

24

STR

GTR

-

None

Recurrence

24/died

25

GTR

-

-

None

No tumor

13/alive

GTR: Gross total resection; Sx: surgery; STR: subtotal resection. Cerebellar findings include dysmetria and dysdiadochokinesia.

tumor showed diabetes insipidus and medical treatment
was started. At the last follow-up, the patient was doing
well. Complication rates showed no significant difference
between interhemispheric-transcallosal and transcortical
approaches (P = 0.13; χ2 test).
3.7. Long-term follow-up
3.7.1. Clinical and radiological outcome
The mean follow-up period in this series was 35.1 ± 15.9
months, ranging from 12 to 61 months (Table 2). Three
patients (12%) died during follow-up. One patient (patient
no. 7 in tables) diagnosed with GBM (grade IV) died 13
months after surgery. Clinical examination of the patient
showed hemiparesis (4/5) and recurrence was noted.
The second patient (patient no. 14 in tables) died after
three surgeries at 12 months of follow-up. The patient’s
first diagnosis was astrocytoma (grade II). Because of

upgrading, first to anaplastic astrocytoma (grade III) and
finally to GBM (grade IV) with a sarcomatous component,
radiation treatment and chemotherapy were given. The
third patient (patient no. 24 in tables) was operated
on twice and diagnoses were astrocytoma (grade II)
and GBM, respectively. The patient received radiation
and chemotherapy but died at 24 months of follow-up.
Considering survival in this series, it was found that the
survival rate was satisfactory and 22 patients (88%) were
still doing well. The last follow-up showed that 18 patients
(81%) had no tumor upon MRI and normal clinical
examination. However, in 4 patients, MRI detected some
degree of residue without progression.
3.7.2. Seizure and antiepileptic drug outcome
Before surgery only one patient (patient no. 20 in tables)
was using AEDs because of seizures that had started 1
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month before surgery. Following surgery, as a routine
procedure, all patients except three patients with 4th
ventricular tumors (i.e. 22 patients) were put on one AED
regimen but at the last follow-up all patients were free of
AEDs without seizure.
4. Discussion
Intraventricular tumors are in general benign in nature
and slow-growing tumors such that clinical symptoms
may not be seen until they reach a certain size. Although
males tend to have these tumors more commonly than
females, there is no sex predominance and the group
differences are not significant (3,6–9). In the present study,
females had these tumors more commonly than males, but
the difference is not significant. In the current literature, it
is clearly seen that there is no specific age range in which
intraventricular tumors are more common (3,10,11).
These tumors can be seen at any age but preferences
of location may be different as children generally have
these tumors in the 4th ventricle. Our patient group was
composed mainly of adults and only three children were
included. Thus, depending solely on our limited number
of cases, we cannot comment on the specific age group.
Lateral ventricles are the commonest location reported so
far, followed by 3rd and 4th ventricles (2,3). Our findings
are in line with literature reports that the lateral ventricle
was the most common location. Incidentally our series
included consecutive patients who had tumors mainly
located in the frontal horn of the lateral ventricles, so our
discussion is mainly limited to this area.
Clinical symptoms are often nonspecific in nature and
they do not develop until the ventricles reach a certain
size. Symptoms are due to increased intracranial pressure
and headache is the most common presentation. Nausea
and vomiting are generally accompanying symptoms.
Other symptoms depending on the location of the tumor
may include imbalance, visual field defects, vertigo,
paresis, and seizures (12,13). Considering patients in this
series, all showed a varying degree of hydrocephalus and
headache was the most common symptom. As reported
previously (12,13), the majority of our patients had normal
neurological examinations.
There have been no side preferences reported so far, as
was the case in our group. It has been demonstrated that the
age of patient, location of tumor in the ventricular system,
and radiological features may provide some clues about
the tumor type or differential diagnosis before surgery
(1–3). In the 3rd ventricle colloid cysts and hypothalamic
glial tumors predominate. In children and adolescents
medulloblastoma and pilocytic astrocytoma are common
in the 4th ventricle. In the lateral ventricle, choroid plexus
tumors are common in children and older age groups
generally show meningiomas, malignant gliomas, or
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metastasis. Central neurocytomas have been reported to
be more common at 40 years of age (8). Subependymomas
are common around the foramen of Monro. Astrocytomas
actually may originate from every part of the ventricular
system. Based on the present series we cannot discuss the
pathology of the 3rd and 4th ventricular system because
of our limited number of patients. Considering the lateral
ventricle, here, for the frontal horn of the lateral ventricle,
central neurocytoma is the most common type, followed
by ependymoma. We have to underline that clinical
reports show different results regarding this diverse group
of tumors because of different numbers and specific ages of
patients included in the series.
The ventricular system is surrounded by vital neuronal
structures and surgical interventions should aim to
remove the tumor as much as possible with minimal or
without severe neurological deficits. Thus, the shortest
distance to the tumor should be chosen. However, there is
no common consensus about the type of surgical approach
to the frontal horn of the lateral ventricle. The surgical
route is straightforward when tumors located in the
temporal and occipital horns and atrium can be removed
by a transcortical approach. For 4th ventricular tumors,
suboccipital craniectomy and telovelar approaches have
been reported to be safe (14). There are several ways to
remove 3rd ventricular tumors that have been very well
explained in the literature (15). Since tumors in the 3rd
ventricle were mainly located in the anterior and superior
parts, we performed an interhemispheric-transcallosal
approach in the present group of patients. The discussion
starts when the tumor is located in the frontal horns of
the lateral ventricle. In the literature, it has been reported
that the ipsilateral anterior horn and body of the lateral
ventricle are best approached by transcortical intervention
(3,4,8,16). In the case of the small ventricle, tumors
involving both the frontal horn and midline are best
removed by an interhemispheric-transcallosal approach.
Some reports further stated that if the ventricular border
is close to the surface, such as less than 2 cm or close to the
very most lateral border, a transcortical approach should be
chosen (8). Decreased incidences of seizure, porencephalic
cyst formation, and subdural hygroma were reported to be
advantages of interhemispheric-transcallosal approaches
(3,4,16). On the other hand, easy access to the ventricles
and manipulation of the tumor, and decreased incidence
of damage to the superior sagittal sinus, large veins, and
vital arteries are advantages of the transcortical route (3,4).
We underline that each route alone or a combination of
both procedures can be used safely with minimal damage
to neurovascular structures. The main reason for choosing
a transcortical approach in our series was the closeness
of large tumors to the very lateral side of the ventricle.
It is very hard to see or control the lateral or superior
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border of large tumors by removing them only by an
interhemispheric-transcallosal approach. In some tumors
located at the midline and extending to one side, they can
be removed safely by a combination of procedures, as we
did in two cases. Thus, there are no strict criteria to choose
one procedure over another and microsurgical techniques
together with the experience of surgical and anesthesia
teams provide satisfactory outcomes. Incidence of seizure
seems to be the same in both types of surgery and subdural
hygroma does not generally cause clinical problems in
these patients.
The complication that required intervention (VPshunt) was hydrocephalus, seen in one patient in our series.
The number of patients requiring VP-shunts is based on
different factors and overall 10% to 50% of patients have
been reported to have hydrocephalus requiring VP-shunts
in the literature (17,18). Since the present study included
patients who had tumors in the frontal horn of the lateral
ventricles only and limited numbers of patients had 3rd
and 4th ventricular tumors, the number of patients who
required a VP-shunt or showed hydrocephalus after
surgery was very small. The true incidence of postoperative
seizures, especially after transcortical incision, is hard to
determine and reports showed different results. Reported
incidence of seizure has been demonstrated from as low
as 3% to as high as 75% (3,4,6,9,16). However, recent
reports showed that increased surgical techniques

together with a new generation of AEDs has reduced the
incidence of seizures and no differences were reported
between transcortical and interhemispheric-transcallosal
approaches (9). We agree with this idea that seizure is not
common after a transcortical approach and only 4 patients
(18.2%) had seizures, which were controlled with AEDs.
In the long-term follow-up no one was taking AEDs and
all were free of seizures. We did not have surgical-related
mortality in the present series and mortality and morbidity
rates were reported to be low (3,4,16). Three deaths in
our group were mainly due to the malignant nature of
the tumors or upgrading of the malignancy in long-term
follow-up.
There are methodological limitations to this study.
First, this study is retrospective and retrieving the data
from patients’ files may have caused bias. Second, the study
should have included a large population of patients and we
included a limited number of patients. Thus, we suggest
that future studies should be prospective and include a
greater number of patients.
In conclusion, surgical removal of intraventricular
tumors is the best option and one approach over another
is not superior in the case of involvement of the frontal
horn of the lateral ventricular. The complication rate
is low when an appropriate surgical route is used. Since
the majority of these tumors are low-grade, total removal
should be the goal of surgery.
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